Martin Mayer
Biography Interests Scholarly Contact Other
Martin Mayer

Scholarly

Abbreviated list of scholarly activity:

  • Foroutan F, Mayer M, Guyatt G, Riley R, Mustafa R, Kruzberger N, Skoetz N, Darzi A, Carolina Alba A, Mowbray F, Rayner D, Schünemann H, Iorio A. GRADE Concept Paper 8: Judging the certainty of discrimination performance estimates of prognostic models in a body of validation studies. J Clin Epidemiol. 2024 Jun:170:111344. doi: 10.1016/j.jclinepi.2024.111344 .

  • Mayer M (2023). {preventr}: An Implementation of the AHA PREVENT Equations. https://CRAN.R-project.org/package=preventr , doi: 10.32614/CRAN.package.preventr .

  • Guyatt G, Zhao Y, Mayer M, Briel M, Mustafa R, Izcovich A, Hultcrantz M, Iorio A, Alba AC, Foroutan F, Sun X, Schünemann H, DeBeer H, Akl EA, Christensen R, Schandelmaier S. GRADE guidance 36: updates to GRADE’s approach to addressing inconsistency. 2023 Jun:158:70-83. doi: 10.1016/j.jclinepi.2023.03.003 .

  • Mayer M. Dichotomies: Often desired, sometimes dubious, and always requiring due diligence. BMJ Evid Based Med. 2022 Apr;27(2):125. doi: 10.1136/bmjebm-2020-111553 .

  • Mayer M. Shared decision making for thromboembolic prophylaxis in non-valvular atrial fibrillation: promise and problems with the American College of Cardiology’s AnticoagEvaluator (based on SPARCtool). BMJ Evid Based Med. 2020 Jun;25(3):90-96. doi: 10.1136/bmjebm-2018-111098 .

  • Mayer M. Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes. Ann Intern Med. 2020 Jan 7;172(1):74. doi: 10.7326/L19-0715 .

    • Additional content that did not make it to the published content is here ⧉.

  • Alper BS, van Zuuren EJ, Price A, Fedorowicz Z, Shaughnessy AF, Oettgen P, Elwyn G, Qaseem A, Kunnamo I, Mayer M. Consistency of recommendations for evaluation and management of hypertension. JAMA Netw Open. 2019 Nov 1;2(11):e1915975. doi: 10.1001/jamanetworkopen.2019.15975 .

    • My last-author placement here is in the traditional fashion of the first and last author being the authors who did the most work. Brian Alper and I served as the senior authors on the paper and the guarantors of the work.

  • Mayer M. Continuous outcome measures: conundrums and conversions contributing to clinical application. BMJ Evid Based Med. 2019 Aug;24(4):133-136. doi: 10.1136/bmjebm-2018-111136 .

    • This includes a supplemental file I created to help users with the calculations involved (interested users should download it if interested in using it).

  • Mayer M. Righteous indignation versus misplaced frustration: p values, CIs, effect sizes and the CASTLE-AF trial. BMJ Evid Based Med. 2019 Jun;24(3):121. pii: bmjebm-2019-111178. doi: 10.1136/bmjebm-2019-111178 . Epub 2019 Feb 27.

  • Mayer M. Research integrity and the law that never was. BMJ Evid Based Med. 2018 Dec;23(6):218-224. doi: 10.1136/bmjebm-2018-110993 . Epub 2018 Sep 11.

  • Mayer M. Direct oral anticoagulants: Handling the literature with care. JAAPA. 2018 Jun;31(6):1-3. doi: 10.1097/01.JAA.0000534932.28345.4b .

  • Mayer M. On P values and effect modification. Int J Evid Based Healthc. 2017 Dec;15(4):144-151. doi: 10.1097/XEB.0000000000000121 . Epub 2017 Sep 8.

  • Mayer M. Anticoagulants in ischemia-guided management of non-ST-elevation acute coronary syndromes. Am J Emerg Med. 2017 Mar;35(3):502-507. doi: 10.1016/j.ajem.2016.12.070 . Epub 2017 Jan 3.

  • Mayer M, Newton D. Primary care “provider” and professional identity. JAMA. 2016 Oct 4;316(13):1411. doi: 10.1001/jama.2016.9775 .

  • Mayer M. Low-density lipoprotein cholesterol goals: still not in patients’ best interest. Evid Based Med. 2016 Aug;21(4):128-133. doi: 10.1136/ebmed-2016-110383 . Epub 2016 Apr 5.

    • Selected as “Editor’s choice” for issue in which it was published

  • Mayer M. How publication bias and inadequate research transparency endanger medicine. JAAPA. 2016 Jun;29(6):1-2. doi: 10.1097/01.JAA.0000483095.89264.81 .

  • Mayer M. Lumacaftor-ivacaftor (Orkambi®) for cystic fibrosis - Behind the “breakthrough”. Evid Based Med. 2016 Jun;21(3):83-86. doi: 10.1136/ebmed-2015-110325 . Epub 2015 Dec 30.

    • Selected as “Editor’s choice” for issue in which it was published

  • Mayer M. Elucidating the use of enoxaparin in non-ST-elevation acute coronary syndromes (NSTE-ACS). Evid Based Med. 2016 Feb;21(1):4-6. doi: 10.1136/ebmed-2015-110275 . Epub 2015 Oct 20.

    • Selected as “Editor’s choice” for issue in which it was published

  • Mayer M. A call to arms to help heal medicine’s greatest ailment - Publication bias and inadequate research transparency. F1000Res. 2015;4:825. doi: 10.12688/f1000research.7037.1 .

    • Qualified for a full waiver of the fees for open access and article processing (sought publication with an open-access journal with open peer review given the topic)

  • Mayer M. Peering into the “rabbit hole” of publication bias and inadequate research transparency: Adding tangibility to the abstract. F1000Res. 2015;4:609. doi: 10.12688/f1000research.6878.2 .

    • Qualified for a full waiver of the fees for open access and article processing (sought publication with an open-access journal with open peer review given the topic)

I’m also a member of the GRADE Working Group and serve on several subgroups. Further general information on scholarly activity and academic contributions to the field of medicine appears on the “Other professional activity” section of the biography page, and more generally, the biography page contains additional information pertinent to my professional contributions and expertise.

Information on published poetry is here.

For more detailed information, please use the contact form.

 | Home